Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04558034 · ClinicalTrials.gov registry record · NA
The Use of Cryotherapy to Prevent Paclitaxel-induced Peripheral Neuropathy and Nail Changes in Women With Breast Cancer
A NA study, sponsored by Parkview Health.
- Terminated
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT04558034: Clinical Trial NA study, sponsored by Parkview Health.
NCT04558034 is a NA study that was terminated before completion, run by Parkview Health. The registered enrollment target is 14 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04558034, a NA study, was terminated before completion, sponsored by Parkview Health.
- TERMINATED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
This study will determine the efficacy of cryotherapy to prevent paclitaxel-induced peripheral neuropathy and nail changes in women with breast cancer.
Primary Outcome
absence of numbness and tingling in the treated hands/feet * If there is an absence of pain in the treated hands/feet * If there is an absence of nail changes in the treated hands/feet
Interventions
- OTHER cryotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2020-08-04 |
| Est. Completion | 2021-02-03 |
| Phase | NA |
Why NCT04558034 stopped before completion
NCT04558034 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which cryotherapy is the first listed.
NCT04558034 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04558034 about?
NCT04558034 is a clinical study titled "The Use of Cryotherapy to Prevent Paclitaxel-induced Peripheral Neuropathy and Nail Changes in Women With Breast Cancer". This study will determine the efficacy of cryotherapy to prevent paclitaxel-induced peripheral neuropathy and nail changes in women with breast cancer.
What is the current status of trial NCT04558034?
This trial is currently terminated. It is a NA study. The enrollment target is 14 participants. The study started on 2020-08-04. Estimated completion is 2021-02-03.
What interventions are being tested in trial NCT04558034?
The interventions under investigation include: cryotherapy (OTHER).
Who is sponsoring clinical trial NCT04558034?
This trial is sponsored by Parkview Health, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04558034's enrollment target sits among peer trials
14 1909th of 2000 higher than 90 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy